LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 1694 | 1976 | 11042 | 0.1790 | 0.0585 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1694 | 2109 | 11099 | 0.1900 | 0.0841 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1694 | 2118 | 11168 | 0.1896 | 0.0855 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 1694 | 1947 | 11042 | 0.1763 | 0.0528 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 1694 | 1971 | 11099 | 0.1776 | 0.0574 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 1694 | 2002 | 11168 | 0.1793 | 0.0633 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1694 | 1830 | 11042 | 0.1657 | 0.0289 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 1694 | 2177 | 11099 | 0.1961 | 0.0969 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 1694 | 1877 | 11168 | 0.1681 | 0.0384 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 1694 | 1676 | 11042 | 0.1518 | -0.0040 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 1694 | 1898 | 11099 | 0.1710 | 0.0428 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 1694 | 1666 | 11168 | 0.1492 | -0.0062 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 1694 | 10926 | 11220 | 0.9737 | 0.9806 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1694 | 11436 | 11309 | 1.0112 | 1.0081 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1694 | 11052 | 11121 | 0.9938 | 0.9954 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1694 | 11164 | 11220 | 0.9949 | 0.9963 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1694 | 11533 | 11309 | 1.0198 | 1.0144 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1694 | 11056 | 11121 | 0.9941 | 0.9957 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 1694 | 10862 | 11220 | 0.9680 | 0.9763 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 1694 | 11568 | 11309 | 1.0229 | 1.0166 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 1694 | 10914 | 11121 | 0.9814 | 0.9862 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 1694 | 11086 | 11220 | 0.9880 | 0.9912 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 1694 | 11599 | 11309 | 1.0256 | 1.0186 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 1694 | 11081 | 11121 | 0.9964 | 0.9973 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1694 | 11122 | 11220 | 0.9912 | 0.9935 |